Jacob Schneider
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacob Schneider has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Jinani Jayasekera
Decision Sciences Research Laboratory, National Institute on Minority Health and Health Disparities, Intramural Research Program, National Institutes of Health, Bethesda, USA
10 shared publications - Emma Tian
Decision Sciences Research Laboratory, National Institute on Minority Health and Health Disparities, Intramural Research Program, National Institutes of Health, Bethesda, USA
7 shared publications - Oliver William Albert Wilson
Division of Intramural Research at the National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, USA
7 shared publications - Richard L. Street
Patient Education and Counseling and Department of Communication and Journalism, Texas A&M University, College Station, TX, USA
5 shared publications - Laura Q. Rogers
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
4 shared publications - Wendy Demark-Wahnefried
Department of Nutrition Sciences, University of Alabama Birmingham, Birmingham, USA
4 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (7) , 662
Correction to: Breast cancer survivors’ perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions
- 16 June 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (7) , 662
Open AccessCorrection to: Breast cancer survivors’ perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions
- Open Access
- 8 June 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e89463
User Perspectives on a Clinical Decision Tool to Support Individualized Exercise Prescriptions for Breast Cancer Survivors Not Meeting Exercise Guidelines: Cross-Sectional Survey
Background: More than 80% of breast cancer survivors do not meet the recommended levels of exercise, and <50% of health care providers promote exercise as part of survivorship care. Patient-provider communication may enhance exercise engagement by increasing patients’ understanding of exercise benefits and linking patients to resources, such as rehabilitation and exercise programs. Objective: This study aimed to explore perspectives on a novel clinical decision tool designed to support individualized exercise discussions and prescriptions among breast cancer survivors who do not meet exercise guidelines and health care providers who primarily treat such survivors. Methods: We conducted a cross-sectional online survey among US breast cancer survivors and health care providers. Participants were (1) female breast cancer survivors aged ≥35 years engaging in ≤150 minutes/week of moderate-intensity aerobic exercise or ≤2 days/week of muscle-strengthening exercise and (2) health care providers who had cared for breast cancer survivors within the past 12 months and reported below-average guideline adherence among their patients. Respondents reviewed a paper draft of a web-based clinical decision prototype tool for supporting individualized exercise discussions and prescriptions based on patients’ demographic, clinical, and contextual characteristics. We assessed perceived usefulness, potential uses (eg, counseling), preferred timing of access within clinical encounters, and preferences for tool characteristics (inputs/outputs). Results: The analytic sample comprised 26 breast cancer survivors and 69 health care providers. The survivors’ median age was 48 (IQR 37-65) years. Providers included patient navigators/social workers/nurses (29/69, 42.0%), breast oncologists (13/69, 18.8%), and occupational/physical therapists (12/69, 17.4%). The majority of providers (62/69, 89.9%, 95% CI 80.2%-95.8%) and survivors (23/26, 88.5%, 95% CI 69.8%-97.6%) reported that they would find the tool useful. Similarly, 85.5% of providers (59/69, 95% CI 75.0%-92.8%) and 84.6% of survivors (22/26, 95% CI 65.1%-95.6%) reported that the tool would increase their confidence to discuss exercise in a clinical setting. Both groups preferred that survivors access the tool with staff after a medical appointment (survivors: 20/26, 76.9%, 95% CI 56.4%-91.0%; providers: 58/67, 86.6%, 95% CI 76.0%-93.7%). Both groups also endorsed treatment history and readiness to exercise to consider as key inputs and improved quality of life and reduced treatment-related side effects as exercise benefits to communicate as tool outputs. Conclusions: The prototype tool concept was well received, with high endorsement of individual characteristics to consider and clinical benefits of exercise to communicate. Findings will inform refinement of the tool and future implementation testing in an understudied population of breast cancer survivors.
- 8 June 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e89463
Open AccessUser Perspectives on a Clinical Decision Tool to Support Individualized Exercise Prescriptions for Breast Cancer Survivors Not Meeting Exercise Guidelines: Cross-Sectional Survey
Background: More than 80% of breast cancer survivors do not meet the recommended levels of exercise, and <50% of health care providers promote exercise as part of survivorship care. Patient-provider communication may enhance exercise engagement by increasing patients’ understanding of exercise benefits and linking patients to resources, such as rehabilitation and exercise programs. Objective: This study aimed to explore perspectives on a novel clinical decision tool designed to support individualized exercise discussions and prescriptions among breast cancer survivors who do not meet exercise guidelines and health care providers who primarily treat such survivors. Methods: We conducted a cross-sectional online survey among US breast cancer survivors and health care providers. Participants were (1) female breast cancer survivors aged ≥35 years engaging in ≤150 minutes/week of moderate-intensity aerobic exercise or ≤2 days/week of muscle-strengthening exercise and (2) health care providers who had cared for breast cancer survivors within the past 12 months and reported below-average guideline adherence among their patients. Respondents reviewed a paper draft of a web-based clinical decision prototype tool for supporting individualized exercise discussions and prescriptions based on patients’ demographic, clinical, and contextual characteristics. We assessed perceived usefulness, potential uses (eg, counseling), preferred timing of access within clinical encounters, and preferences for tool characteristics (inputs/outputs). Results: The analytic sample comprised 26 breast cancer survivors and 69 health care providers. The survivors’ median age was 48 (IQR 37-65) years. Providers included patient navigators/social workers/nurses (29/69, 42.0%), breast oncologists (13/69, 18.8%), and occupational/physical therapists (12/69, 17.4%). The majority of providers (62/69, 89.9%, 95% CI 80.2%-95.8%) and survivors (23/26, 88.5%, 95% CI 69.8%-97.6%) reported that they would find the tool useful. Similarly, 85.5% of providers (59/69, 95% CI 75.0%-92.8%) and 84.6% of survivors (22/26, 95% CI 65.1%-95.6%) reported that the tool would increase their confidence to discuss exercise in a clinical setting. Both groups preferred that survivors access the tool with staff after a medical appointment (survivors: 20/26, 76.9%, 95% CI 56.4%-91.0%; providers: 58/67, 86.6%, 95% CI 76.0%-93.7%). Both groups also endorsed treatment history and readiness to exercise to consider as key inputs and improved quality of life and reduced treatment-related side effects as exercise benefits to communicate as tool outputs. Conclusions: The prototype tool concept was well received, with high endorsement of individual characteristics to consider and clinical benefits of exercise to communicate. Findings will inform refinement of the tool and future implementation testing in an understudied population of breast cancer survivors.
- Open Access
- 8 May 2026
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (S2) , 1997-2008
Healthcare provider perspectives on barriers and facilitators to exercise promotion among breast cancer survivors: Differences across professions
Purpose: The extent to which exercise promotion (discussion and/or referral) barriers and facilitators in the care of breast cancer survivors differ across healthcare professions is currently unclear. This study aimed to describe differences in barriers and facilitators based on profession. Methods: Healthcare providers (oncologists/primary care physicians, cancer exercise-related professionals, allied healthcare providers) who had cared for breast cancer survivors aged ≥ 35-years in the past year participated in an online survey regarding cancer survivor exercise promotion barriers and facilitators. Prevalence ratios (PR) comparing differences in agreement for barriers and facilitators across professions were computed using Modified Poisson regression models. Results: Data were collected from 177 providers, including oncologists / primary care physicians (n = 68, 38.4%), exercise-related professionals (n = 67, 37.9%), and allied healthcare providers (n = 42, 23.7%). Differences were found across professions. For instance, compared with exercise-related professionals, oncologists / primary care physicians had a higher prevalence of agreement that limited time to discuss exercise (PR = 1.48, 95%CI:1.12–1.94), exercise being medically unsafe for patients (PR = 1.62, 95%CI:1.06–2.49), and not being convinced of the exercise and cancer outcomes literature (PR = 2.00, 95%CI:1.03–3.91) were barriers to exercise promotion. Conclusions: Exercise promotion barriers and facilitators appear to differ across professions. Exercise-related professionals appear to be less constrained by a lack of time and concerns about the safety of exercise, while oncologists appear unconvinced of exercise and cancer outcome evidence. Implications for Cancer Survivors: Exercise promotion efforts should consider the available time and competing responsibilities of each survivorship care team member, and better disseminate information regarding the safety and benefits of exercise to mitigate the risk of healthcare providers being unaware.
- 8 May 2026
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (S2) , 1997-2008
Open AccessHealthcare provider perspectives on barriers and facilitators to exercise promotion among breast cancer survivors: Differences across professions
Purpose: The extent to which exercise promotion (discussion and/or referral) barriers and facilitators in the care of breast cancer survivors differ across healthcare professions is currently unclear. This study aimed to describe differences in barriers and facilitators based on profession. Methods: Healthcare providers (oncologists/primary care physicians, cancer exercise-related professionals, allied healthcare providers) who had cared for breast cancer survivors aged ≥ 35-years in the past year participated in an online survey regarding cancer survivor exercise promotion barriers and facilitators. Prevalence ratios (PR) comparing differences in agreement for barriers and facilitators across professions were computed using Modified Poisson regression models. Results: Data were collected from 177 providers, including oncologists / primary care physicians (n = 68, 38.4%), exercise-related professionals (n = 67, 37.9%), and allied healthcare providers (n = 42, 23.7%). Differences were found across professions. For instance, compared with exercise-related professionals, oncologists / primary care physicians had a higher prevalence of agreement that limited time to discuss exercise (PR = 1.48, 95%CI:1.12–1.94), exercise being medically unsafe for patients (PR = 1.62, 95%CI:1.06–2.49), and not being convinced of the exercise and cancer outcomes literature (PR = 2.00, 95%CI:1.03–3.91) were barriers to exercise promotion. Conclusions: Exercise promotion barriers and facilitators appear to differ across professions. Exercise-related professionals appear to be less constrained by a lack of time and concerns about the safety of exercise, while oncologists appear unconvinced of exercise and cancer outcome evidence. Implications for Cancer Survivors: Exercise promotion efforts should consider the available time and competing responsibilities of each survivorship care team member, and better disseminate information regarding the safety and benefits of exercise to mitigate the risk of healthcare providers being unaware.
- 3 April 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (9) , 1705-1714
Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019
Background: We evaluated county-level variations in racial and/or ethnic disparities in breast cancer mortality rates across the United States over a 20-year period. Methods: Validated small-area estimation models were used to calculate breast cancer mortality rates by age and race and/or ethnicity among females across all United States counties from 2000 to 2019. The estimates were corrected for misreporting of race and/or ethnicity on death certificates and age-standardized to the 2010 United States Census. Results: Age-standardized national breast cancer mortality rates declined between 2000 and 2019, from 33.6 (95% uncertainty interval = 33.4-33.9) to 24.8 (24.6-25.0) deaths per 100 000 females. However, there were variations in breast cancer mortality rates across racial and/or ethnic populations at the county level. For instance, 243 of 1478 counties showed increasing breast cancer mortality rates from 2000 to 2019 among Latina females aged <50 years (absolute increase [median] = 0.23 deaths per 100 000; maximum = 1.0). County-level patterns for American Indian/Alaska Native females aged 50-74 years showed increasing breast cancer mortality rates across 108 of 474 counties (median = 4.4 per 100 000; max = 17.5). The largest county-level increases were seen among American Indian/Alaska Native (184 of 474 counties; median = 15.2 per 100 000; max = 124.0) and Asian (589 of 667 counties; median = 14.1 per 100 000, max = 41.0) females aged 75+ years. Conclusions: Despite a substantial decrease in overall breast cancer mortality rates across all female populations combined in the United States, there were significant county-level variations in breast cancer mortality rates by race and/or ethnicity.
- 3 April 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (9) , 1705-1714
Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019
Background: We evaluated county-level variations in racial and/or ethnic disparities in breast cancer mortality rates across the United States over a 20-year period. Methods: Validated small-area estimation models were used to calculate breast cancer mortality rates by age and race and/or ethnicity among females across all United States counties from 2000 to 2019. The estimates were corrected for misreporting of race and/or ethnicity on death certificates and age-standardized to the 2010 United States Census. Results: Age-standardized national breast cancer mortality rates declined between 2000 and 2019, from 33.6 (95% uncertainty interval = 33.4-33.9) to 24.8 (24.6-25.0) deaths per 100 000 females. However, there were variations in breast cancer mortality rates across racial and/or ethnic populations at the county level. For instance, 243 of 1478 counties showed increasing breast cancer mortality rates from 2000 to 2019 among Latina females aged <50 years (absolute increase [median] = 0.23 deaths per 100 000; maximum = 1.0). County-level patterns for American Indian/Alaska Native females aged 50-74 years showed increasing breast cancer mortality rates across 108 of 474 counties (median = 4.4 per 100 000; max = 17.5). The largest county-level increases were seen among American Indian/Alaska Native (184 of 474 counties; median = 15.2 per 100 000; max = 124.0) and Asian (589 of 667 counties; median = 14.1 per 100 000, max = 41.0) females aged 75+ years. Conclusions: Despite a substantial decrease in overall breast cancer mortality rates across all female populations combined in the United States, there were significant county-level variations in breast cancer mortality rates by race and/or ethnicity.
- Open Access
- 15 March 2026
- Published by SAGE Publications in Women's Health
- Vol. 22
Clinical and sociodemographic characteristics associated with health-related quality of life among older breast cancer survivors
Background: Health-related quality of life (HRQoL) measures may help incorporate patient preferences and deliver individualized care for older breast cancer survivors. However, few studies have used clinically meaningful thresholds to evaluate the various characteristics associated with HRQoL in older women. Objectives: To examine sociodemographic and clinical characteristics associated with HRQoL and minimal clinically important differences (MCIDs) among female breast cancer survivors aged ⩾65 years. Design: A cross-sectional study. Methods: We used 2006–2015 Surveillance, Epidemiology, and End Results data linked to the Medicare Health Outcomes Survey (SEER-MHOS) for U.S. women aged ⩾65 years diagnosed with stages I–III invasive breast cancer. Descriptive statistics were used to summarize data. Generalized linear regression models were fitted to identify characteristics associated with the HRQoL physical component summary (PCS) and mental component summary (MCS) scores from the Veterans RAND 12-Item Health Survey scale. Missing values were imputed using chained equations. A threshold of two points was used to identify clinically meaningful between-group differences. Results: The median age at diagnosis was 72 years (interquartile range: 68–76) among 3218 breast cancer survivors. Obesity (mean difference (MD): −2.42; 95% confidence interval (CI): −3.34, −1.49), older age (⩾80 years; MD: −2.05; 95% CI: −3.15, −0.96), difficulty with ⩾1 activities of daily living (ADL; MD: −11.70; 95% CI: −12.42, −10.99), and cardiovascular (MD: −2.27; 95% CI: −3.02, −1.53) and musculoskeletal disease (MD: −3.88; 95% CI: −4.67, −3.09) were associated with clinically meaningful lower PCS scores. Less than high school education (MD: −3.43; 95% CI: −4.53, −2.33), annual household income ≤$19,999 (MD: −4.08; 95% CI: −6.00, −2.16) and $20,000–$39,999 (MD: −2.71; 95% CI: −4.63, −0.79), no surgery (MD: −3.03; 95% CI: −5.33, −0.72), difficulty with ≥1 ADL (MD: −6.71; 95% CI: −7.52, −5.89), and obesity (MD:2.06; 95% CI: 1.00, 3.12) were associated with MCIDs in MCS scores. Conclusion: Clinically meaningful differences in HRQoL were observed across sociodemographic and clinical characteristics in older female breast cancer survivors. These results may help identify women in need of interventions to improve HRQoL post-diagnosis.
- 15 March 2026
- Published by SAGE Publications in Women's Health
- Vol. 22
Open AccessClinical and sociodemographic characteristics associated with health-related quality of life among older breast cancer survivors
Background: Health-related quality of life (HRQoL) measures may help incorporate patient preferences and deliver individualized care for older breast cancer survivors. However, few studies have used clinically meaningful thresholds to evaluate the various characteristics associated with HRQoL in older women. Objectives: To examine sociodemographic and clinical characteristics associated with HRQoL and minimal clinically important differences (MCIDs) among female breast cancer survivors aged ⩾65 years. Design: A cross-sectional study. Methods: We used 2006–2015 Surveillance, Epidemiology, and End Results data linked to the Medicare Health Outcomes Survey (SEER-MHOS) for U.S. women aged ⩾65 years diagnosed with stages I–III invasive breast cancer. Descriptive statistics were used to summarize data. Generalized linear regression models were fitted to identify characteristics associated with the HRQoL physical component summary (PCS) and mental component summary (MCS) scores from the Veterans RAND 12-Item Health Survey scale. Missing values were imputed using chained equations. A threshold of two points was used to identify clinically meaningful between-group differences. Results: The median age at diagnosis was 72 years (interquartile range: 68–76) among 3218 breast cancer survivors. Obesity (mean difference (MD): −2.42; 95% confidence interval (CI): −3.34, −1.49), older age (⩾80 years; MD: −2.05; 95% CI: −3.15, −0.96), difficulty with ⩾1 activities of daily living (ADL; MD: −11.70; 95% CI: −12.42, −10.99), and cardiovascular (MD: −2.27; 95% CI: −3.02, −1.53) and musculoskeletal disease (MD: −3.88; 95% CI: −4.67, −3.09) were associated with clinically meaningful lower PCS scores. Less than high school education (MD: −3.43; 95% CI: −4.53, −2.33), annual household income ≤$19,999 (MD: −4.08; 95% CI: −6.00, −2.16) and $20,000–$39,999 (MD: −2.71; 95% CI: −4.63, −0.79), no surgery (MD: −3.03; 95% CI: −5.33, −0.72), difficulty with ≥1 ADL (MD: −6.71; 95% CI: −7.52, −5.89), and obesity (MD:2.06; 95% CI: 1.00, 3.12) were associated with MCIDs in MCS scores. Conclusion: Clinically meaningful differences in HRQoL were observed across sociodemographic and clinical characteristics in older female breast cancer survivors. These results may help identify women in need of interventions to improve HRQoL post-diagnosis.
- Open Access
- 29 January 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (2) , 139
Breast cancer survivors’ perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions
Purpose: To examine breast cancer survivors’ perspectives on the prototype (paper-draft) of a clinical decision tool to support individualized exercise prescriptions and discussions within clinical settings. Methods: A sample of ≥90 female breast cancer survivors aged ≥35 years across the U.S. were recruited to complete an online survey that collected data on survivors’ characteristics and perspectives of a prototype of the tool. Survey items were adapted from validated pre-existing instruments and refined via cognitive interviews. Results: Ninety-eight of the 142 individuals screened were deemed eligible and completed the survey. Most breast cancer survivors agreed that a tool would be useful (84.7%) and increase confidence to discuss exercise with a healthcare provider (74.5%). Among tool uses, the highest agreement was found for education (84.1%) and encouragement to exercise (79.3%). Improving the ability to do everyday tasks (74.0%), quality-of-life (72.6%), and energy (71.4%) were rated as the top exercise benefits to include in a tool. Agreement on tool usefulness, uses, and inputs varied by survivors’ demographic, clinical, and contextual characteristics. For example, agreement that a tool would increase their confidence to discuss exercise was lower among younger survivors (<50 years, 67.7%) than older survivors (≥50 years, 78.5%). Conclusions: An evidence-based clinical decision tool offering individualized exercise information could support exercise prescriptions and discussions within clinical settings. However, a one-size-fits-all tool may not address existing disparities in exercise participation. Further research among underserved women is needed.
- 29 January 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (2) , 139
Open AccessBreast cancer survivors’ perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions
Purpose: To examine breast cancer survivors’ perspectives on the prototype (paper-draft) of a clinical decision tool to support individualized exercise prescriptions and discussions within clinical settings. Methods: A sample of ≥90 female breast cancer survivors aged ≥35 years across the U.S. were recruited to complete an online survey that collected data on survivors’ characteristics and perspectives of a prototype of the tool. Survey items were adapted from validated pre-existing instruments and refined via cognitive interviews. Results: Ninety-eight of the 142 individuals screened were deemed eligible and completed the survey. Most breast cancer survivors agreed that a tool would be useful (84.7%) and increase confidence to discuss exercise with a healthcare provider (74.5%). Among tool uses, the highest agreement was found for education (84.1%) and encouragement to exercise (79.3%). Improving the ability to do everyday tasks (74.0%), quality-of-life (72.6%), and energy (71.4%) were rated as the top exercise benefits to include in a tool. Agreement on tool usefulness, uses, and inputs varied by survivors’ demographic, clinical, and contextual characteristics. For example, agreement that a tool would increase their confidence to discuss exercise was lower among younger survivors (<50 years, 67.7%) than older survivors (≥50 years, 78.5%). Conclusions: An evidence-based clinical decision tool offering individualized exercise information could support exercise prescriptions and discussions within clinical settings. However, a one-size-fits-all tool may not address existing disparities in exercise participation. Further research among underserved women is needed.
- 1 January 2026
- Published by Human Kinetics in Journal of Physical Activity and Health
- p. 1-13
Development of an Exercise Question Prompt List for Breast Cancer Survivors
Background : High-quality communication about exercise during clinical visits may increase participation among breast cancer survivors. However, survivors’ exercise participation and communication preferences remain poorly understood. The aims of this study were to synthesize existing evidence on breast cancer survivors’ exercise participation and communication preferences and to refine a question prompt list (QPL) with expert input. Methods : A systematic scoping review was conducted in accordance with PRISMA-ScR guidelines. Five databases were searched for articles reporting survivors’ exercise participation and communication preferences worldwide between January 2005 and July 2025. Survivor characteristics and exercise preferences were extracted and used to draft a QPL. Weighted average percentages for preferences were calculated. Experts provided feedback through interviews, and the QPL was iteratively revised accordingly. Results : Twenty-nine studies were identified. Overall, preferences were found for exercise frequency (77.6%: ≥2 sessions/wk), intensity (63.1%: moderate intensity), and duration (62.9%: 30–60 min/session). Preferred locations included home (29.3%), community recreation facilities (32.9%), and outdoors (31.4%). Supervised exercise (53.4%) and exercising with others (57.7%) were preferred over unsupervised (35.2%) and solo (34.4%) exercise, respectively. Survivors preferred exercise counseling/advice from an exercise specialist (59.3%) and face-to-face delivery (63.7%). Experts (n = 10) viewed the QPL favorably and recommended modifications to improve comprehension, as well as additional questions on willingness to pay and travel for exercise, and interest in diet/nutrition information. Conclusions : Survivor preferences and expert input are reflected in the novel QPL. With further testing, the QPL may support the delivery of guideline-aligned exercise information. Future research should evaluate the QPL’s impact on survivors’ exercise participation and psychological antecedents of exercise (eg, self-efficacy).
- 1 January 2026
- Published by Human Kinetics in Journal of Physical Activity and Health
- p. 1-13
Development of an Exercise Question Prompt List for Breast Cancer Survivors
Background : High-quality communication about exercise during clinical visits may increase participation among breast cancer survivors. However, survivors’ exercise participation and communication preferences remain poorly understood. The aims of this study were to synthesize existing evidence on breast cancer survivors’ exercise participation and communication preferences and to refine a question prompt list (QPL) with expert input. Methods : A systematic scoping review was conducted in accordance with PRISMA-ScR guidelines. Five databases were searched for articles reporting survivors’ exercise participation and communication preferences worldwide between January 2005 and July 2025. Survivor characteristics and exercise preferences were extracted and used to draft a QPL. Weighted average percentages for preferences were calculated. Experts provided feedback through interviews, and the QPL was iteratively revised accordingly. Results : Twenty-nine studies were identified. Overall, preferences were found for exercise frequency (77.6%: ≥2 sessions/wk), intensity (63.1%: moderate intensity), and duration (62.9%: 30–60 min/session). Preferred locations included home (29.3%), community recreation facilities (32.9%), and outdoors (31.4%). Supervised exercise (53.4%) and exercising with others (57.7%) were preferred over unsupervised (35.2%) and solo (34.4%) exercise, respectively. Survivors preferred exercise counseling/advice from an exercise specialist (59.3%) and face-to-face delivery (63.7%). Experts (n = 10) viewed the QPL favorably and recommended modifications to improve comprehension, as well as additional questions on willingness to pay and travel for exercise, and interest in diet/nutrition information. Conclusions : Survivor preferences and expert input are reflected in the novel QPL. With further testing, the QPL may support the delivery of guideline-aligned exercise information. Future research should evaluate the QPL’s impact on survivors’ exercise participation and psychological antecedents of exercise (eg, self-efficacy).
- Open Access
- 15 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
User Perspectives on a Clinical Decision Tool to Support Individualized Exercise Prescriptions for Breast Cancer Survivors Not Meeting Exercise Guidelines: Cross-Sectional Survey (Preprint)
BACKGROUND More than 80% of breast cancer survivors do not meet the recommended levels of exercise, and <50% of health care providers promote exercise as part of survivorship care. Patient-provider communication may enhance exercise engagement by increasing patients’ understanding of exercise benefits and linking patients to resources, such as rehabilitation and exercise programs. OBJECTIVE This study aimed to explore perspectives on a novel clinical decision tool designed to support individualized exercise discussions and prescriptions among breast cancer survivors who do not meet exercise guidelines and health care providers who primarily treat such survivors. METHODS We conducted a cross-sectional online survey among US breast cancer survivors and health care providers. Participants were (1) female breast cancer survivors aged ≥35 years engaging in ≤150 minutes/week of moderate-intensity aerobic exercise or ≤2 days/week of muscle-strengthening exercise and (2) health care providers who had cared for breast cancer survivors within the past 12 months and reported below-average guideline adherence among their patients. Respondents reviewed a paper draft of a web-based clinical decision prototype tool for supporting individualized exercise discussions and prescriptions based on patients’ demographic, clinical, and contextual characteristics. We assessed perceived usefulness, potential uses (eg, counseling), preferred timing of access within clinical encounters, and preferences for tool characteristics (inputs/outputs). RESULTS The analytic sample comprised 26 breast cancer survivors and 69 health care providers. The survivors’ median age was 48 (IQR 37-65) years. Providers included patient navigators/social workers/nurses (29/69, 42.0%), breast oncologists (13/69, 18.8%), and occupational/physical therapists (12/69, 17.4%). The majority of providers (62/69, 89.9%, 95% CI 80.2%-95.8%) and survivors (23/26, 88.5%, 95% CI 69.8%-97.6%) reported that they would find the tool useful. Similarly, 85.5% of providers (59/69, 95% CI 75.0%-92.8%) and 84.6% of survivors (22/26, 95% CI 65.1%-95.6%) reported that the tool would increase their confidence to discuss exercise in a clinical setting. Both groups preferred that survivors access the tool with staff after a medical appointment (survivors: 20/26, 76.9%, 95% CI 56.4%-91.0%; providers: 58/67, 86.6%, 95% CI 76.0%-93.7%). Both groups also endorsed treatment history and readiness to exercise to consider as key inputs and improved quality of life and reduced treatment-related side effects as exercise benefits to communicate as tool outputs. CONCLUSIONS The prototype tool concept was well received, with high endorsement of individual characteristics to consider and clinical benefits of exercise to communicate. Findings will inform refinement of the tool and future implementation testing in an understudied population of breast cancer survivors.
- 15 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUser Perspectives on a Clinical Decision Tool to Support Individualized Exercise Prescriptions for Breast Cancer Survivors Not Meeting Exercise Guidelines: Cross-Sectional Survey (Preprint)
BACKGROUND More than 80% of breast cancer survivors do not meet the recommended levels of exercise, and <50% of health care providers promote exercise as part of survivorship care. Patient-provider communication may enhance exercise engagement by increasing patients’ understanding of exercise benefits and linking patients to resources, such as rehabilitation and exercise programs. OBJECTIVE This study aimed to explore perspectives on a novel clinical decision tool designed to support individualized exercise discussions and prescriptions among breast cancer survivors who do not meet exercise guidelines and health care providers who primarily treat such survivors. METHODS We conducted a cross-sectional online survey among US breast cancer survivors and health care providers. Participants were (1) female breast cancer survivors aged ≥35 years engaging in ≤150 minutes/week of moderate-intensity aerobic exercise or ≤2 days/week of muscle-strengthening exercise and (2) health care providers who had cared for breast cancer survivors within the past 12 months and reported below-average guideline adherence among their patients. Respondents reviewed a paper draft of a web-based clinical decision prototype tool for supporting individualized exercise discussions and prescriptions based on patients’ demographic, clinical, and contextual characteristics. We assessed perceived usefulness, potential uses (eg, counseling), preferred timing of access within clinical encounters, and preferences for tool characteristics (inputs/outputs). RESULTS The analytic sample comprised 26 breast cancer survivors and 69 health care providers. The survivors’ median age was 48 (IQR 37-65) years. Providers included patient navigators/social workers/nurses (29/69, 42.0%), breast oncologists (13/69, 18.8%), and occupational/physical therapists (12/69, 17.4%). The majority of providers (62/69, 89.9%, 95% CI 80.2%-95.8%) and survivors (23/26, 88.5%, 95% CI 69.8%-97.6%) reported that they would find the tool useful. Similarly, 85.5% of providers (59/69, 95% CI 75.0%-92.8%) and 84.6% of survivors (22/26, 95% CI 65.1%-95.6%) reported that the tool would increase their confidence to discuss exercise in a clinical setting. Both groups preferred that survivors access the tool with staff after a medical appointment (survivors: 20/26, 76.9%, 95% CI 56.4%-91.0%; providers: 58/67, 86.6%, 95% CI 76.0%-93.7%). Both groups also endorsed treatment history and readiness to exercise to consider as key inputs and improved quality of life and reduced treatment-related side effects as exercise benefits to communicate as tool outputs. CONCLUSIONS The prototype tool concept was well received, with high endorsement of individual characteristics to consider and clinical benefits of exercise to communicate. Findings will inform refinement of the tool and future implementation testing in an understudied population of breast cancer survivors.
- Open Access
- 1 October 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 9 (9) , e2500151
Development and Validation of a Simulation Model–Based Tool to Support Individualized Physical Activity Discussions and Prescriptions for Breast Cancer Survivors
PURPOSE: Clinical guidelines recommend offering individualized physical activity prescriptions to cancer survivors. However, there are limited tools to support individualized physical activity discussions and prescriptions. We developed and validated a simulation model–based tool to estimate individualized survival outcomes for postdiagnosis physical activity among postmenopausal breast cancer survivors. METHODS: We adapted an established simulation modeling approach developed within the Cancer Intervention and Surveillance Modeling Network to estimate breast cancer–specific and all-cause survival associated with postdiagnosis physical activity for 50- to 75-year-old (postmenopausal) women with stage I to III invasive breast cancer. Model estimates were generated for 60,480 subgroups based on age, weight status (BMI), stage, tumor subtype, treatment, aerobic (<30 min/wk [no/minimal], ≥30 to <150 min/wk [insufficient], ≥150 to <300 min/wk [active], ≥300 min/wk [highly active]), and muscle-strengthening (<2 or ≥2 d/wk) activity. The outcomes were 10-year survival and absolute survival benefits for different levels of physical activity by individual characteristics and treatment. Model inputs were derived from trials, cohort studies, registry, and surveillance data. External validation used independent data. RESULTS: Survival rates and absolute benefits for physical activity varied by age, weight status, stage, tumor subtype, and amount and type of activity. For example, the 10-year breast cancer–specific and all-cause survival for no/minimal activity in a 65- to 69-year-old-woman with stage II, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer with obesity was 79.2% and 72.2%, respectively. Increasing aerobic activity from no/minimal to insufficient activity with <2 d/wk of muscle-strengthening was associated with absolute increases in 10-year breast cancer–specific and all-cause survival by 2.8 and 3.4 percentage points, respectively. The model closely replicated survival rates in independent data. CONCLUSION: Simulation model–based estimates could support clinical tools for guideline-recommended individualized discussions and physical activity prescriptions for breast cancer survivors.
- 1 October 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 9 (9) , e2500151
Open AccessDevelopment and Validation of a Simulation Model–Based Tool to Support Individualized Physical Activity Discussions and Prescriptions for Breast Cancer Survivors
PURPOSE: Clinical guidelines recommend offering individualized physical activity prescriptions to cancer survivors. However, there are limited tools to support individualized physical activity discussions and prescriptions. We developed and validated a simulation model–based tool to estimate individualized survival outcomes for postdiagnosis physical activity among postmenopausal breast cancer survivors. METHODS: We adapted an established simulation modeling approach developed within the Cancer Intervention and Surveillance Modeling Network to estimate breast cancer–specific and all-cause survival associated with postdiagnosis physical activity for 50- to 75-year-old (postmenopausal) women with stage I to III invasive breast cancer. Model estimates were generated for 60,480 subgroups based on age, weight status (BMI), stage, tumor subtype, treatment, aerobic (<30 min/wk [no/minimal], ≥30 to <150 min/wk [insufficient], ≥150 to <300 min/wk [active], ≥300 min/wk [highly active]), and muscle-strengthening (<2 or ≥2 d/wk) activity. The outcomes were 10-year survival and absolute survival benefits for different levels of physical activity by individual characteristics and treatment. Model inputs were derived from trials, cohort studies, registry, and surveillance data. External validation used independent data. RESULTS: Survival rates and absolute benefits for physical activity varied by age, weight status, stage, tumor subtype, and amount and type of activity. For example, the 10-year breast cancer–specific and all-cause survival for no/minimal activity in a 65- to 69-year-old-woman with stage II, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer with obesity was 79.2% and 72.2%, respectively. Increasing aerobic activity from no/minimal to insufficient activity with <2 d/wk of muscle-strengthening was associated with absolute increases in 10-year breast cancer–specific and all-cause survival by 2.8 and 3.4 percentage points, respectively. The model closely replicated survival rates in independent data. CONCLUSION: Simulation model–based estimates could support clinical tools for guideline-recommended individualized discussions and physical activity prescriptions for breast cancer survivors.
- Open Access
- 2 July 2025
- Published by Springer Nature in Quality of Life Research
- p. 1-17
Recreational physical activity and health-related quality of life among breast cancer survivors: a systematic review
Purpose: Breast cancer survivors are at increased risk of poor health-related quality of life (HRQOL). Clinical trials suggest physical activity interventions may improve HRQOL, however, evidence on whether these benefits extend to physical activity in real-world settings is limited. We aimed to evaluate the association between post-diagnosis recreational physical activity and HRQOL among breast cancer survivors in the observational literature and compare findings with clinical trial data. Methods: A systematic review was conducted, searching seven databases for studies published between January 2003 and October 2024. Study characteristics and adjusted analyses of the association between recreational physical activity and HRQOL were extracted. A qualitative synthesis categorized HRQOL outcomes into global, physical, emotional, social, and breast cancer-specific domains. Risk of bias was assessed, and findings from observational studies were compared with those from clinical trials. Results: The search identified 5831 sources, with 11 studies meeting inclusion criteria. For most domains, studies reported positive associations between aerobic activity and HRQOL. Meeting aerobic activity guidelines was found to have clinically meaningful positive associations with global HRQOL (Five studies), physical HRQOL (Two studies), and breast cancer-specific HRQOL (One study). Fewer studies reported on emotional/social domains of HRQOL or the association between muscle-strengthening activity and HRQOL. Overall, observational findings were consistent with clinical trial findings. Conclusions: Observational evidence suggests that aerobic activity guideline adherence may be associated with increased global and physical HRQOL. These findings indicate that benefits observed in trials may extend to real-world recreational aerobic activity. Further research is needed on muscle-strengthening activity and activity dosage.
- 2 July 2025
- Published by Springer Nature in Quality of Life Research
- p. 1-17
Open AccessRecreational physical activity and health-related quality of life among breast cancer survivors: a systematic review
Purpose: Breast cancer survivors are at increased risk of poor health-related quality of life (HRQOL). Clinical trials suggest physical activity interventions may improve HRQOL, however, evidence on whether these benefits extend to physical activity in real-world settings is limited. We aimed to evaluate the association between post-diagnosis recreational physical activity and HRQOL among breast cancer survivors in the observational literature and compare findings with clinical trial data. Methods: A systematic review was conducted, searching seven databases for studies published between January 2003 and October 2024. Study characteristics and adjusted analyses of the association between recreational physical activity and HRQOL were extracted. A qualitative synthesis categorized HRQOL outcomes into global, physical, emotional, social, and breast cancer-specific domains. Risk of bias was assessed, and findings from observational studies were compared with those from clinical trials. Results: The search identified 5831 sources, with 11 studies meeting inclusion criteria. For most domains, studies reported positive associations between aerobic activity and HRQOL. Meeting aerobic activity guidelines was found to have clinically meaningful positive associations with global HRQOL (Five studies), physical HRQOL (Two studies), and breast cancer-specific HRQOL (One study). Fewer studies reported on emotional/social domains of HRQOL or the association between muscle-strengthening activity and HRQOL. Overall, observational findings were consistent with clinical trial findings. Conclusions: Observational evidence suggests that aerobic activity guideline adherence may be associated with increased global and physical HRQOL. These findings indicate that benefits observed in trials may extend to real-world recreational aerobic activity. Further research is needed on muscle-strengthening activity and activity dosage.